NDC product
STASIS
NDC 10129-031 · Gingi-Pak a Division of the Belport
Key facts
| Product NDC | 10129-031 |
|---|---|
| Proprietary name | STASIS |
| Nonproprietary name | Ferric Sulfate |
| Substances | FERRIC SULFATE |
| Dosage form | SOLUTION |
| Route | DENTAL, PERIODONTAL, SUBGINGIVAL |
| Labeler | Gingi-Pak a Division of the Belport |
| Product type | HUMAN OTC DRUG |
| Marketing category | UNAPPROVED DRUG OTHER |
| Pharmacologic classes | Iron [CS], Parenteral Iron Replacement [EPC], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA] |
| Marketing start | Jun 26, 1987 |
| Listing certified through | Dec 31, 2027 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: